Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01260935 · ClinicalTrials.gov registry record · NA

Comparison of Laparoscopic Hill and Laparoscopic Nissen Anti-Reflux Procedures

A NA study of Gastroesophageal Reflux and Gastroesophageal Reflux Disease, sponsored by Swedish Medical Center.

Completed
Registry status
NA
Development phase
121
Enrollment target
1
Study location

NCT01260935 is a NA study of Gastroesophageal Reflux and Gastroesophageal Reflux Disease that has completed, run by Swedish Medical Center. The registered enrollment target is 121 participants, below the 180-participant average among 25 other Gastroesophageal Reflux trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01260935, a NA study of Gastroesophageal Reflux and Gastroesophageal Reflux Disease, has completed, sponsored by Swedish Medical Center.

COMPLETED
Registry status
NA
Development phase
121 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the effects (good and bad) of the Laparoscopic Hill anti-reflux procedure with the Laparoscopic Nissen anti-reflux surgical procedure to see whether one is better than the other.

Interventions

  • PROCEDURE Laparoscopic Hill Repair
  • PROCEDURE Laparoscopic Nissen Repair

Study Locations (1)

Washington

  • Swedish Medical Center Cancer Institute - Seattle

Trial Details

FieldValue
Enrollment Target 121 participants
Start Date 2002-11
Est. Completion 2010-11
Phase NA

Sponsor

Swedish Medical Center

30 total trials

What the Registry Record Tells You About NCT01260935

The ClinicalTrials.gov registry entry for NCT01260935 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 180-participant average among 25 other Gastroesophageal Reflux trials with a reported enrollment target (33% lower). The listed sponsor is Swedish Medical Center, which has 30 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Gastroesophageal Reflux appearing as the primary indexed condition, and to 2 interventions - of which Laparoscopic Hill Repair is the first listed.

NCT01260935 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT01260935 about?

NCT01260935 is a clinical study titled "Comparison of Laparoscopic Hill and Laparoscopic Nissen Anti-Reflux Procedures". The purpose of this study is to compare the effects (good and bad) of the Laparoscopic Hill anti-reflux procedure with the Laparoscopic Nissen anti-reflux surgical procedure to see whether one is better than the other.

What is the current status of trial NCT01260935?

This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2002-11. Estimated completion is 2010-11.

What conditions does trial NCT01260935 study?

This clinical trial studies the following conditions: Gastroesophageal Reflux, Gastroesophageal Reflux Disease, GERD, Esophageal Reflux.

What interventions are being tested in trial NCT01260935?

The interventions under investigation include: Laparoscopic Hill Repair (PROCEDURE), Laparoscopic Nissen Repair (PROCEDURE).

Who is sponsoring clinical trial NCT01260935?

This trial is sponsored by Swedish Medical Center, which has 30 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01260935 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gastroesophageal Reflux

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.